Form D · Biotechnology
3D Bio Holdings, Inc.
Brooklyn, NY · CIK 0001662010
Offering snapshot reported Apr 10, 2019 · SEC filing
- Reported sold
- $5.03M Offering amount: $15M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 5, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 10, 2019 | Initial | $5,029,995 | No comparison | 9 | SEC filing |
| Jul 13, 2017 | Initial | $2,200,000 | No comparison | 1 | SEC filing |
| Apr 10, 2017 | Initial | $25,000 | No comparison | 1 | SEC filing |
| Aug 12, 2016 | Amendment | $500,000 | $250,000vs May 27, 2016 | 2 | SEC filing |
| May 27, 2016 | Initial | $250,000 | No comparison | 1 | SEC filing |
| May 19, 2016 | Amendment | $705,000 | $440,000vs Jan 4, 2016 | 17 | SEC filing |
| Jan 4, 2016 | Initial | $265,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-336911
Source: Form D, filed Apr 10, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Michael G. Bator | Director |
| Daniel L. Cohen | Director, Executive |
| Matthew A. Fitzpatrick | Director |
| Harlan F. Weisman | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2 St. Nicholas Avenue Suite 53
Brooklyn, NY, 11237
Brooklyn, NY, 11237